(120 days)
The Hysteroscopy Pump HM6 is intended to provide liquid distension of the uterus during diagnostic and operative hysteroscopy, and to monitor the volume differential between the irrigation fluid flowing into and out of the uterus.
The Hysteroscopy Pump HM6 is a microprocessor controlled device that consists of the following two main components: (1) an irrigation pump unit and (2) and fluid monitoring unit that are to be placed on a cart. The irrigation pump unit is a single roller pump that functions according to the peristaltic system and includes a manmachine interface (MMI) and a touch-screen display. The Hysteroscopy Pump HM6 is to be used with specially designed single use irrigation and outflow tube sets that are supplied sterile. The fluid monitoring unit of the Hysteroscopy Pump HM6 is a microprocessor controlled device, which monitors the amount of delivered irrigation solution and compares it with the volume of the secretions returned to the container. The monitoring enables the surgeon to observe the quantity of fluids left in the patient. The irrigation pump unit of the proposed device indicates any fluid deficit that exceeds the fluid deficit level pre-set by the surgeon. The Hysteroscopy Pump HM6 determines both the inflow and outflow volume by means of two separate scales.
This document describes a 510(k) premarket notification for the Hysteroscopy Pump HM6. The focus of the submission is to demonstrate substantial equivalence to predicate devices, rather than establishing de novo safety and effectiveness through extensive clinical studies with acceptance criteria. Therefore, the information provided is primarily focused on demonstrating the similarity of the new device to existing devices on the market, relying on bench testing for performance.
Here's an analysis of the provided information concerning acceptance criteria and studies:
1. A table of acceptance criteria and the reported device performance
The document does not explicitly present a table of acceptance criteria with corresponding performance data in the traditional sense of a clinical trial proving a specific efficacy or accuracy metric. Instead, the "performance testing" section refers to bench tests and compliance with standards. The key "acceptance criterion" for this 510(k) submission is showing that the device is substantially equivalent to predicate devices and that the modifications do not raise new questions of safety and effectiveness.
The document highlights the following performance aspects and their comparison to the predicate Aquilex System:
| Acceptance Criterion (Implied) | Reported Device Performance (Hysteroscopy Pump HM6) |
|---|---|
| Accuracy of fluid deficit measurement | Improved to = 0% compared to = 10% for the predicate device (Aquilex System) due to a separate scale for inflow volume. |
| Maximum selectable pressure | Identical to the Aquilex System (150 mmHg). |
| Safety features (e.g., active pressure reduction, overpressure warnings, fluid deficit warnings) | Same or similar to predicate devices. |
| Software validation | Performed in accordance with FDA Guidance document "General Principles of Software Validation", with the software considered "Major Level of Concern". |
| Electrical Safety and EMC | Performed in accordance with IEC 60601-1 by an accredited test institute. |
| Design modifications (mechanics, hardware, software) | Results from internal design control process, including risk analysis. Validation and verification testing of system specifications performed as bench tests. |
| Tubing design and material | Identical to the Aquilex System, with minor length changes and addition of a clamp for the outflow tube set. |
| Fluid bag detection feature | New safety feature informs user if fluid in bag is <= 500 ml. |
2. Sample sized used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)
The document primarily describes bench testing and compliance with standards. It does not mention clinical studies involving human subjects or specific "test sets" in that context. Therefore, information regarding human sample size, data provenance (country of origin), or retrospective/prospective nature is not applicable here. The testing would have been conducted internally by the manufacturer or by accredited test institutes.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)
This is not applicable as the submission relies on bench testing and adherence to standards, not expert-adjudicated clinical data to establish ground truth for a test set.
4. Adjudication method (e.g. 2+1, 3+1, none) for the test set
Not applicable, as there is no mention of a human-adjudicated test set.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
Not applicable. This device is a Hysteroscopy Pump, a medical equipment, not an AI-powered diagnostic or interpretive tool that would involve human readers or AI assistance.
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done
Not applicable. This device is a physical medical pump with integrated software, not a standalone algorithm. Its performance is evaluated through its physical function and software control, not as an isolated algorithm.
7. The type of ground truth used (expert concensus, pathology, outcomes data, etc)
For the performance claims made, the "ground truth" would be established by:
- Bench testing measurements: For fluid volume accuracy, pressure control, flow rates, etc., the ground truth would be precise measurements obtained through calibrated instruments in a controlled laboratory setting.
- Compliance with standards: For electrical safety and EMC, the ground truth is adherence to the specifications outlined in IEC 60601-1.
- Design control documentation: For software validation and mechanical/hardware design, the ground truth is adherence to internal design specifications and risk analyses.
8. The sample size for the training set
Not applicable, as this device's development does not involve machine learning or AI models that require a "training set" of data in the common sense. The software would have been developed through traditional software engineering processes, with testing conducted on the specific device and its components.
9. How the ground truth for the training set was established
Not applicable, as there is no "training set" as understood in machine learning contexts.
{0}------------------------------------------------
K123732
pg. 1 of 4
WORLD OF M Hysteroscopy Pump HIV Special 510(k) Premarket Notification
APR 0 4 2013
510(k) SUMMARY OF SAFETY & EFFECTIVENESS
Submitter:
W.O.M. WORLD OF MEDICINE AG Salzufer 8 10587 Berlin Germany
Phone: +49 30 399 81 594 +49 30 399 81 593 Fax:
Contact Person:
Susanne Raab Regulatory Consultant 1480 Cambridge Street Cambridge, MA 02139
Phone: (617) 547-0628 (617) 520-2401 Fax: e-mail: sbraab@comcast.net
Date Prepared:
December 4, 2012
Tube Sets
II
Trade Name:
Hysteroscopy Pump HM6 Hysteroscopic Insufflator, Fluid Monitoring System and
Common Name:
Classification Name:
Hystersoscopic Insufflator and Accessories under 21 C.F.R. 884.1700
Regulatory Class:
HIG Product Code:
{1}------------------------------------------------
K123732
Pg. 2 of 4
Predicate Devices:
Device Description:
The Hysteroscopy Pump HM6 is a microprocessor controlled device that consists of the following two main components: (1) an irrigation pump unit and (2) and fluid monitoring unit that are to be placed on a cart. The irrigation pump unit is a single roller pump that functions according to the peristaltic system and includes a manmachine interface (MMI) and a touch-screen display. The Hysteroscopy Pump HM6 is to be used with specially designed single use irrigation and outflow tube sets that are supplied sterile. The fluid monitoring unit of the Hysteroscopy Pump HM6 is a microprocessor controlled device, which monitors the amount of delivered irrigation solution and compares it with the volume of the secretions returned to the container. The monitoring enables the surgeon to observe the quantity of fluids left in the patient. The irrigation pump unit of the proposed device indicates any fluid deficit that exceeds the fluid deficit level pre-set by the surgeon. The Hysteroscopy Pump HM6 determines both the inflow and outflow volume by means of two separate scales.
Intended Use:
The Hysteroscopy Pump HM6 is intended to provide liquid distension of the uterus during diagnostic and operative hysteroscopy, and to monitor the volume differential between the irrigation fluid flowing into and out of the uterus.
Summary of Similarities and Differences in Technological Characteristics:
The proposed device Hysteroscopy Pump HM6 is a modified version of the Aquilex Fluid Control System H112, K112642, (the "Aquilex System"). The Hysteroscopy Pump HM6 and the Aquilex System use the same basic operating principles and incorporate the same basic design including materials. Specifically, the Hysteroscopy Pump HM6 and the Aquilex System incorporate the following main components: (i) an irrigation pump unit, (ii) a fluid monitoring unit, and (iii) an inflow and an outflow tube set.
The irrigation pump units of both the proposed device Hysteroscopy Pump HM6 and Aquilex System are all electro-mechanical and microprocessor controlled devices that function according to the peristaltic principle. Both the Hysteroscopy Pump HM6 and the Aquilex System utilize a pressure sensor to monitor the intrauterine pressure. To achieve the desired pressure within the cavity, the pressure sensor of both the Hysteroscopy Pump HM6 and the Aquilex System are connected to a processor that controls the speed of the roller wheel and thus the volume of fluid that is delivered into the cavity. The maximum selectable pressure of the Hysteroscopy Pump HM6 is identical to that of the Aquilex System (150 mmHg). Furthermore, both the Hysteroscopy Pump HM6 and the predicate devices are
{2}------------------------------------------------
K123732
pg. 3 of 4
designed with the same or similar setting keys, display elements and safety features (e.g. active pressure reduction, overpressure warnings and fluid deficit warnings). The fluid monitoring unit of both the proposed device Hysteroscopy Pump HM6 and Aquilex System are micro-processor controlled devices, which monitor the amount of delivered irrigation solution and compare it with the volume of the secretions returned to the container. The fluid monitoring unit consists of the following main components: (1) scale, (2) a support plate, (3), a bag holder, (4) a container holder, and (5) a roller base. Finally, the inflow tube set and outflow tube set of the proposed device Hysteroscopy Pump HM6 is identical in design, material, packaging and sterilization to the inflow and outflow tube set of the Aquilex System except for a minor change to the length of the tubing that is attached to the Yconnector of the inflow tube set and the equipment of the outflow tube set with an additional clamp. Also, the outflow tube set of the Hysteroscopy Pump HM6 is not designed with suction connectors.
The modification to the predicate device Aquilex System consists of a change in software and design. The main differences are related to the inclusion of a manmachine interface (MMI) including a 7" touch-screen and to the incorporation of a separate scale for determination of the inflow volume. Also, unlike the Aquilex System, the Hysteroscopy Pump HM6 is not equipped with vacuum pumps and therefore, not capable of applying suction. Other minor differences include the location of the roller wheel at the front of the device, a reduction of the maximum flow rate, the ability to choose a flow rate, the ability to use the irrigation pump unit without fluid monitoring unit and the optional performance of the instrument detection feature.
Substantial Equivalence:
The Hysteroscopy Pump HM6 is substantially equivalent to the Aquilex System (K112642) and to the Hysteroscopy Pump HM4 (K022449). The proposed device has the same intended use as the predicate devices. In addition, both the proposed device and the predicate devices incorporate the same fundamental scientific technology. Specifically, both the predicate device and the predicate devices use the same basic operating principles and incorporate the same basic design.
The differences between the Hysteroscopy Pump HM6 and the predicate device Aquilex System are minor and do not raise new questions of safety and effectiveness.
Specifically, the implementation of an interactive man-machine interface (MMI) including a 7" touch screen display into the proposed device as well as the modification that are related the above changes (e.g. incorporation of a faster processor, larger casing of the irrigation pump unit, optional display of the set flow rate and graphical display fluid deficit in % of the set pressure limit) improve the ease of use of the proposed device and do not raise new questions of safety and effectiveness. In addition, the incorporations of a separate scale to determine the
{3}------------------------------------------------
inflow volume for calculation of the fluid deficit including any related modifications inflow volume for carculation of the fictiveness. Not only improves the use of a separate scale the accuracy of the fluid deficit measurement from volume a separate state hic accuracy of and to the predicate device Aquilex System but measurement = 10 % to = 0 % compared to my fluid bag detection feature as a new safety feature that informs the user if the fluid in the fluid bag is <= 500 ml. With safely feature that informs the user it the front of the device, the reduction regards to the location of the roller m.select a flow rate, the ability to use of the irrigation pump unit without fluid monitoring unit and the optional performance of the instrument detection feature, the proposed device is substantially equivalent to the predicate device Hysteroscopy Pump HM6. In addition, all other minor the predicale device frysterosoopy railip of safety and effectiveness. Finally, testing demonstrates that the differences between the Hysteroscopy Pump HM6 and the predicate devices that the differences of safety and effectiveness. Based the predicate devices do not indication for use and the similiarities in technolegy.
on the same intended use and indication for use and the similiaries in technology. on the same intended use and marcared 101 abstantially equivalent to its predicate devices.
Performance Testing:
The design modifications, which affect both the mechanical, hardware and software I he design modifications, which affect bour the results from the internal design control process, including risk analysis.
Validation and verification testing of the system specification were performed as bench tests.
Software validation was performed in accordance with the FDA Guidance document Software validation was portomice talidation". The Software of the Hysteroscopy "Ocrneral" 6 is considered "Major Level of Concern".
Electrical Safety and EMC testing was performed in accordance with IEC 60601-1 by an accredited test institute.
The labeling has been updated to reflect the design modifications.
Conclusion:
Based on the same intended use the similiarities in technolgy, design and materials, Based on the same intended use the sminitality equivalent to its predicate devices.
the Hysteroscopy Pump HM6 is substantially equivalent to its predicate as minor the Hysteroscopy Tullip Thilo is Sacotanana the predicate devices are minor
The differnences between the proposed device and the predicate devices are minor The differnetices new questions of safety and effectiveness.
{4}------------------------------------------------
Image /page/4/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle with its wings spread, and the words "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" are arranged in a circular pattern around the eagle. The logo is black and white.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
April 4, 2013
W.O.M. WORLD OF MEDICINE AG % Ms. Susanne Raab Regulatory Consultant 1480 Cambridge Street CAMBRIDGE MA 02139
Re: K123732
Trade/Device Name: Hysteroscopy Pump HM6 Regulation Number: 21 CFR§ 884.1700 Regulation Name: Hysteroscopic insufflator Regulatory Class: II Product Code: HIG Dated: March 18, 2013 Received: March 21, 2013
Dear Ms. Raab:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies.
{5}------------------------------------------------
You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely yours,
Image /page/5/Picture/6 description: The image shows the name "Benjamin R. Fisher - S" in a stylized font. The letters "R" and "F" are stylized with a geometric pattern. The name is written in black ink on a white background.
Benjamin R. Fisher, Ph.D. Director Division of Reproductive, Gastro-Renal, and Urological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{6}------------------------------------------------
Image /page/6/Picture/0 description: The image shows a logo with a circle and a design inside, followed by the text "WORLD OF MEDICINE". Below that, it says "Hysteroscopy Pump HM6" and "Special 510(k) Premarket Notification". The text appears to be advertising or providing information about a medical device.
INDICATIONS FOR USE STATMENT
K123732 510(k) Number (if known): Device Name: Hystersocopy Pump HM6
Indications for Use:
The Hysteroscopy Pump HM6 is intended to provide liquid distension of the uterus during diagnostic and operative hysteroscopy, and to monitor the volume differential between the irrigation fluid flowing into and out of the uterus.
Prescription Use X Over-The-Counter Use AND/OR (Part 21 CFR 801 Subpart D) (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Benjamin R. Fisher 2013.04.04 18:12:43 -04.00
Page 1 of 1
(Division Sign-Off) Division of Reproductive, Gastro-Renal, and Urological Devices 510(k) Number
§ 884.1700 Hysteroscopic insufflator.
(a)
Identification. A hysteroscopic insufflator is a device designed to distend the uterus by filling the uterine cavity with a liquid or gas to facilitate viewing with a hysteroscope.(b)
Classification. (1) Class II (performance standards).(2) Class I for tubing and tubing/filter fits which only include accessory instruments that are not used to effect intrauterine access, e.g., hysteroscopic introducer sheaths, etc.; and single-use tubing kits used for only intrauterine insufflation. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807 of this chapter, subject to the limitations in § 884.9.